Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report)’s stock price traded up 0.6% during mid-day trading on Thursday . The company traded as high as $18.62 and last traded at $17.78. 119,358 shares changed hands during mid-day trading, an increase of 138% from the average session volume of 50,104 shares. The stock had previously closed at $17.67.
Neoleukin Therapeutics Price Performance
The business’s 50 day moving average price is $17.89 and its 200-day moving average price is $30.31. The company has a market cap of $156.95 million, a P/E ratio of -5.37 and a beta of 1.11.
Neoleukin Therapeutics Company Profile
Neoleukin Therapeutics, Inc, a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma.
Further Reading
- Five stocks we like better than Neoleukin Therapeutics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Are Treasury Bonds?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How Can Investors Benefit From After-Hours Trading
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Neoleukin Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neoleukin Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
